Glucosamine Ineffective for Lower Back Pain Linked to... (the researchers evaluated the patients' ...)

Glucosamine Ineffective for Lower Back Pain Linked to Arthritis

Date:7/7/2010

the researchers evaluated the patients' self-reported quality of life.

At the start of the 6-month trial, patients taking glucosamine scored 9.2 on the pain scale while the patients taking placebo scored 9.7, the researchers note. At the 6-month point, both groups scored 5.0, and after one year the glucosamine group scored 4.8 while the placebo group scored 5.5, Wilkens's group found.

However, the small differences in scores at six months or one year were not statistically significant, the researchers say. Nor were minor differences in quality of life between the two groups deemed significant.

The bottom line, according to Wilkens: "People with chronic low back pain and degenerative osteoarthritis will not benefit more from glucosamine than placebo for treating their back problem."

Dr. Andrew L. Avins, a scientist in the division of research at Kaiser Permanente Northern California and the author of an accompanying journal editorial, said that, "from a clinical standpoint, the study demonstrates that glucosamine does not appear to be better than placebo for patients with chronic low back pain and spinal arthritis."

However, the study found no ill effects from taking the supplement. So, patients who take glucosamine and feel that it is helping them should be reassured that it's at least not harmful, said Avins, who is also professor of medicine, epidemiology & biostatistics at the University of California, San Francisco.

"The larger implications [of this study] are that we still know very little about how to help most patients with chronic low back pain, and we need much more careful, directed research to help make progress in providing relief to patients with back pain," he added.

Even though back pain is an incredibly important public health and quality of life problem, it suffers from insufficient attention and research funding, Avins believes. "In the U.S., we spend far more on treatments of little or questionable va
'/>"/>

1

GOOD

Page: 1 2 3
Related medicine news :

1. Yearly Chlamydia Screening May Be Ineffective for Some
2. Attitudes, beliefs and health literacy impact how patients manage chronic lower-back pain
3. 2010 Tornado Season ends with lower fatalities
4. Intensively lowering glucose: Possible benefits must be weighed against risks
5. Statins May Lower Rates of Prostate Cancer Recurrence
6. Lower back pain and surgery
7. Statins associated with lower cancer recurrence following prostatectomy
8. Healthier cafeteria food, more intense gym classes lower students diabetes risk
9. Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds
10. Reported surgical quality measures not associated with lower infection rates
11. Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk

Post Your Comments:

Related Image:

Glucosamine Ineffective for Lower Back Pain Linked to Arthritis

(Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is on ... hours a week of applied behavior analysis (ABA) therapy ... Autism and Related Disorders (CARD). Riley has been in ... remarkable progress, including learning to speak, starting conversations, making ... through autism is now featured in CARD’s “Mission Possible: ...

(Date:6/18/2013)... have launched an innovative clinical trial, unique in ... a patient,s own stem cells to prevent leg ... , Led by Vik Kashyap, MD, Division ... Center,s Harrington Heart & Vascular Institute and Professor ... of Medicine, the clinical trial is designed to ...

(Date:6/18/2013)... More than 1.1 million people in the U.S. ages 13 ... for Disease Control and Prevention (CDC). Of those, nearly 20 ... HIV Testing Day on June 27, Allsup, a nationwide provider ... CDC and other organizations are raising awareness of the importance ... new HIV infections each year. Along with developing AIDS, those ...

(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...

(Date:6/18/2013)... FL (PRWEB) June 18, 2013 A ... by storm. The burgeoning aquaculture industry is redefining the ... one of the most acclaimed personal culinary chefs on ... clientele on benefits of sustainable seafood and the promising ... in abundance these days. Many consumers strive to fully ...

Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3 Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2 Health News:New $119 Million Industry Swimming Up the East Coast 2

[0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation [0] Allsup Observes National HIV Testing Day June 27 [0] myCNAjobs Adds New Resources to Growing Caregiver Career Center [0] New $119 Million Industry Swimming Up the East Coast

... When family members ask physicians not to disclose bad ... balance their obligation to be truthful to the patient ... harmful. To help clinicians more successfully manage these conflicts, ... in collaboration with colleagues at Stanford University, have developed ...

... Ellex Medical Lasers,Limited (ASX: ELX), a global ... and ultrasound systems, announced today that the initial,results ... will be presented by Peter Hamilton MD, FRCOph ... Ophthalmology, which takes place,November 10-13, in New Orleans. ...

... Inc. announced,completion of the company,s Phase 1 clinical ... for the treatment of inflammatory,diseases linked to the ... Phase 1 trial for AM803, a second oral ... AM103 and AM803 are novel inhibitors of 5-lipoxygenase-activiting,protein ...

... tool for 50% faster miRNA preparation with no,detectable large RNA ... ... developing area of RNAi, ST. LOUIS, Nov. 1 ... Kit,( http://www.sigma.com/mirna ) for purification of miRNA from diverse,biological sources. ...

... - 20% U.S. Sequential Quarterly Sales Increase ... - FY08 Revenue Projection Raised - ... - Conference Call to be Held at 10:00 a.m. Central Time Today -, ... million for the second quarter,of fiscal 2008 ended September 30, 2007, up 73% from $1.8 ...

... Sales up 11.2% and Earnings Per Diluted Share up 20% Excluding Tax Items ... ... Fourth Quarter - - Conference ... West Pharmaceutical,Services, Inc. (NYSE: WST ) today announced the results of operations for,the ...

Don't tell mother she has cancer Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter West Pharmaceutical Services Announces Third Quarter 2007 Results

(Date:6/18/2013)... 2013 New-generation electronic designs are focused ... lightweight. Simultaneously, circuitry is increasing the number of ... which it performs at. Connecting cables from the ... equipment, such as cameras or detectors, must be ... connectors include custom cable designs for high-quality signal ...

(Date:6/18/2013)... EMERYVILLE, Calif. , June 18, 2013 ... today from a Phase 2/3 clinical trial of ... statistically significant improvement in levodopa-induced dyskinesia (LID) as ... versus placebo in the Unified Dyskinesia Rating Scale ... amantadine intended for once-nightly administration that is being ...

(Date:6/18/2013)... 2013 Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...

Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6 Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2 Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3

[0] Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility [0] Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease [0] Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients

... /PRNewswire-Asia/ -- Neusoft Corporation ("Neusoft", 600718.SH), a leading ... announced that its wholly-owned subsidiary Neusoft Europe Inc. ... Aerotel Medical Systems Ltd. ("Aerotel"), a leading global ... and telecare solutions based in Israel, under which ...

... Leading events organiser UBM Live is today ... ICSE, P-MEC and BioPh Japan events in Tokyo as a ... have now been rescheduled and will be held from 13-15 ... business community is intent on picking itself up as quickly ...

Cached Medicine Technology:Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market 2 Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 2 Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 3

Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Immunoglobulin G, CSF Immunoglobulin A, CSF Immunofixation Electrophoresis Gel Immunocytochemistry